SEC 13F Intelligence

Altium Capital Management LLC / CAPR

Altium Capital Management LLC’s Capricor Therapeutics Inc Position

Does Altium Capital Management LLC own Capricor Therapeutics Inc (CAPR)? Not currently — the last reported position was 714.0K shares worth $10M in Q4 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$10M
Q4 2024
Shares
714.0K
% of Portfolio
+2.79%
Quarters Held
2
position exited

Position History CAPR

Reported value by quarter
Q3 ’24: $4MQ3 ’24Q4 ’24: $10MQ4 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2024714.0K$10M+2.79%
Q3 2024285.0K$4M+1.28%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Altium Capital Management LLC’s full portfolio or all institutional holders of CAPR.